Manuela di Fusco (Manuela Di Fusco)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 29

Top Topics

Cross Sectional

Pulmonary Embolism

Respiratory Syndrome Coronavirus

Top Venues

Expert review of vaccines

Journal of medical economics

Healthcare (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Manuela di Fusco, Xiaowu Sun, Kristen E Allen, Alon Yehoshua, Alexandra Berk, Mary B Alvarez, Thomas M Porter, Jinma Ren, Laura Puzniak, Santiago M C Lopez, Joseph Christopher Cappelleri
Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide Study. Vaccines 12 (2) (2024)
Shailja Vaghela, Verna L Welch, Anup Sinh, Manuela di Fusco
Caregiver Burden among Patients with Influenza or Influenza-like Illness (ILI): A Systematic Literature Review. Healthcare (Basel, Switzerland) 12 (16) (2024)
Shailja Vaghela, Verna L Welch, Anup Sinh, Manuela di Fusco
Caregiver Burden among Patients with Influenza or Influenza-like Illness (ILI): A Systematic Literature Review. Healthcare (Basel, Switzerland) 12 (16) (2024)
Manuela di Fusco, Xiaowu Sun, Kristen E Allen, Alon Yehoshua, Alexandra Berk, Mary B Alvarez, Thomas M Porter, Jinma Ren, Laura Puzniak, Santiago M C Lopez, Joseph Christopher Cappelleri
Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide Study. Vaccines 12 (2) (2024)
Diana Mendes, Ruth Chapman, Elena Aruffo, Peter Gal, Jennifer L Nguyen, Libby Hamson, Manuela di Fusco, Carole Czudek, Jingyan Yang
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance. Expert review of vaccines (2023)
Manuela di Fusco, Joseph C Cappelleri, Laura Anatale-Tardiff, Henriette Coetzer, Alon Yehoshua, Mary B Alvarez, Kristen E Allen, Thomas M Porter, Laura Puzniak, Ashley S Cha-Silva, Santiago M C Lopez, Xiaowu Sun
Impact of COVID-19 Infection on Health-Related Quality of Life, Work Productivity and Activity Impairment by Symptom-Based Long COVID Status and Age in the US. Healthcare (Basel, Switzerland) 11 (20) (2023)
Manuela di Fusco, Kinga Marczell, Elizabeth Thoburn, Timothy L Wiemken, Jingyan Yang, Benjamin Yarnoff
Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (original and omicron BA.4/BA.5) in the United States. Journal of medical economics (2023)
Manuela di Fusco, Xiaowu Sun, Mary M Moran, Henriette Coetzer, Joann M Zamparo, Mary B Alvarez, Laura Puzniak, Ying P Tabak, Joseph C Cappelleri
Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron. Journal of patient-reported outcomes 7 (1) (2023)
Diana Mendes, Ruth Chapman, Elena Aruffo, Peter Gal, Jennifer L Nguyen, Libby Hamson, Manuela di Fusco, Carole Czudek, Jingyan Yang
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance. Expert review of vaccines 22 (1) (2023)
Manuela di Fusco, Xiaowu Sun, Laura Anatale-Tardiff, Alon Yehoshua, Henriette Coetzer, Mary B Alvarez, Kristen E Allen, Thomas M Porter, Laura Puzniak, Santiago M C Lopez, Joseph Christopher Cappelleri
Impact of Bivalent BA.4/5 BNT162b2 COVID-19 Vaccine on Acute Symptoms, Quality of Life, Work Productivity and Activity Levels among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy. Vaccines 11 (11) (2023)
Diana Mendes, Ruth Chapman, Elena Aruffo, Peter Gal, Jennifer L Nguyen, Libby Hamson, Manuela di Fusco, Carole Czudek, Jingyan Yang
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance. Expert review of vaccines 22 (1) (2023)
Diana Mendes, Ruth Chapman, Elena Aruffo, Peter Gal, Jennifer L Nguyen, Libby Hamson, Manuela di Fusco, Carole Czudek, Jingyan Yang
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance. Expert review of vaccines 22 (1) (2023)
Manuela di Fusco, Shailja Vaghela, Mary M Moran, Jay Lin, Jessica E Atwell, Deepa Malhotra, Thomas Scassellati Sforzolini, Alejandro Cane, Jennifer L Nguyen, Leah J McGrath
COVID-19-associated hospitalizations among children less than 12 years of age in the United States. Journal of medical economics 25 (1) (2022)
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela di Fusco, Timothy Lee Wiemken, Moe H Kyaw, John M McLaughlin, Jennifer L Nguyen
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert review of vaccines (2022)
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela di Fusco, Timothy Lee Wiemken, Moe Htet Kyaw, John M McLaughlin, Jennifer L Nguyen
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert review of vaccines 22 (1) (2022)
Manuela di Fusco, Kinga Marczell, Kristen A Deger, Mary M Moran, Timothy L Wiemken, Alejandro Cane, Solène de Boisvilliers, Jingyan Yang, Shailja Vaghela, Julie Roiz
Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States. Journal of medical economics 25 (1) (2022)
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela di Fusco, Timothy Lee Wiemken, Moe Htet Kyaw, John M McLaughlin, Jennifer L Nguyen
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert review of vaccines 22 (1) (2022)
Manuela di Fusco, Jay Lin, Shailja Vaghela, Melissa Lingohr-Smith, Jennifer L Nguyen, Thomas Scassellati Sforzolini, Jennifer Judy, Alejandro Cane, Mary M Moran
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies. Expert review of vaccines 21 (4) (2022)
Diana Mendes, Ruth Chapman, Peter Gal, Jessica Atwell, Jennifer L Nguyen, Libby Hamson, Manuela di Fusco, Carole Czudek, Jingyan Yang
Public health impact of booster vaccination against COVID-19 in the UK during Delta variant dominance in autumn 2021. Journal of medical economics 25 (1) (2022)
Manuela di Fusco, Xiaowu Sun, Mary M Moran, Henriette Coetzer, Joann M Zamparo, Laura Puzniak, Mary B Alvarez, Ying P Tabak, Joseph C Cappelleri
Impact of COVID-19 and effects of BNT162b2 on patient-reported outcomes: quality of life, symptoms, and work productivity among US adult outpatients. Journal of patient-reported outcomes 6 (1) (2022)
Steven Deitelzweig, Evelien Bergrath, Manuela di Fusco, Amiee Kang, Mirko Savone, Joseph Christopher Cappelleri, Cristina Russ, Marissa Blieden Betts, Allie Cichewicz, Kassandra Schaible, Jialu Tarpey, Kyle Fahrbach
Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis. Future cardiology 18 (5) (2022)
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela di Fusco, Timothy Lee Wiemken, Moe Htet Kyaw, John M McLaughlin, Jennifer L Nguyen
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert review of vaccines 22 (1) (2022)
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela di Fusco, Timothy Lee Wiemken, Moe H Kyaw, John M McLaughlin, Jennifer L Nguyen
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert review of vaccines (2022)
Diana Mendes, Ruth Chapman, Elena Aruffo, Peter Gal, Jennifer L Nguyen, Libby Hamson, Manuela di Fusco, Carole Czudek, Jingyan Yang
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance. Expert review of vaccines (2022)
Manuela di Fusco, Mary M Moran, Alejandro Cane, Daniel Curcio, Farid Khan, Deepa Malhotra, Andy Surinach, Amanda Miles, David Swerdlow, John M McLaughlin, Jennifer L Nguyen
Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2. Journal of medical economics 24 (1) (2021)
Manuela di Fusco, Kimberly M Shea, Jay Lin, Jennifer L Nguyen, Frederick J Angulo, Michael Benigno, Deepa Malhotra, Birol Emir, Anita H Sung, Jennifer L Hammond, Sophia Stoychev, Apostolos Charos
Health outcomes and economic burden of hospitalized COVID-19 patients in the United States. Journal of medical economics 24 (1) (2021)
Matthew Sussman, Manuela di Fusco, Charles Y Tao, Jennifer D Guo, John A Gillespie, Mauricio Ferri, Nicholas Adair, Matthew S Cato, Ilnaz Shirkhorshidian, Geoffery D Barnes
The IMPact of untReated nOn-Valvular atrial fibrillation on short-tErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF model. Journal of medical economics 24 (1) (2021)
Steven Deitelzweig, Manuela di Fusco, Amiee Kang, Mirko Savone, Ruth Mokgokong, Allison Keshishian, Cynthia Gutierrez, Joseph Christopher Cappelleri
Real-world persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis. Current medical research and opinion 37 (6) (2021)
Matthew Sussman, Geoffery D Barnes, Jennifer D Guo, Charles Y Tao, John A Gillespie, Mauricio Ferri, Nicholas Adair, Matthew S Cato, Ilnaz Shirkhorshidian, Manuela di Fusco
The burden of undertreatment and non-treatment among patients with non-valvular atrial fibrillation and elevated stroke risk: a systematic review. Current medical research and opinion (2021)